Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PLTR vs GSK✓SelectedUSD · GSKPLTR vs GSK performance historyLatest closeAs of-6.63%11/20
Stock and ETF performance explorer

PLTR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-7.9%
GSK return
+6.1%
Excess return
-14.0%
Maximum drawdown
-44.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.6%-0.1%-6.5%-6.7%
7D-14.6%-5.3%-9.3%-15.5%
30D-28.9%-3.7%-25.2%-29.2%
3M-17.5%-7.3%-10.3%-18.7%
6M+4.6%-4.2%+8.9%+4.5%
YTD-19.3%+0.9%-20.1%-21.1%
1Y-7.9%+7.3%-15.1%-10.8%
All-7.9%+6.1%-14.0%-10.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling